/C O R R E C T I O N -- Altesa Biosciences Inc./

In the news release, Altesa BioSciences Presents Novel Clinical Data Demonstrating Vapendavir Significantly Reduces Key Inflammatory Biomarkers in Rhinovirus-Challenged COPD Patients at the European Respiratory Society International Congress 2026, issued 08-Sep-2026 by Altesa Biosciences...